Of interest, analysis of our microarray gene expression data from a large study with TAM-treated breast cancer patients [38] showed that high FOXM1 mRNA expression in tumors was associated with a less good patient survival (Figure 1C). This evidence concerns the gene FOXM1 and breast carcinoma.